Evidence for Genetic Basis of Multiple Sclerosis
Lancet 347:1728-1730, Sadovnick,A.D.,et al, 1996
Clinical and Subclinical Neurological Involvement in Children of Conjugal Multiple Sclerosis Patients
Multiple Sclerosis 1:170-172, Constantinescu,C.S.,et al, 1996
Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Multiple Sclerosis of the Spinal Cord:Magnetic Resonance Appearance
J Comput Assist Tomogr 20:434-438, Thielan,K.R.&Miller,G.M., 1996
Sporadic Corticosteroid Pulses and Osteoporosis in Multiple Sclerosis
Arch Neurol 53:753-757, Schwid,S.R.,et al, 1996
A Study of Oligoclonal Band Negative Multiple Sclerosis
JNNP 60:28-30, Zeman,A.Z.J.,et al, 1996
Refractory Epilepsy:Comparison of MR Imaging, CT, and Histopathologic Findings in 117 Patients
Radiology 201:97-105, Bronen,R.A.,et al, 1996
Motor Neuron Disease, Lymphoproliferative Disease, and Bone Marrow Biopsy
Muscle & Nerve 19:1334-1337996., Louis,E.D.,et al, 1996
Bilateral Ptosis Due to Mesencephalic Lesions with Relative Preservation of Ocular Motility
J Neuro-Ophthalmol 16:258-263, Martin,T.J.,et al, 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996
Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996
Age on Onset, Sex, & Cardiomyopathy as Predictors of Disability and Survival in Friedreich's Disease
Neurol 47:1260-1264, DeMichele,G.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Periodic Lateralized Epileptiform Discharges in Multiple Sclerosis
Electroenceph Clin Neurophysiol 98:5-8, Shabolla,D.R.,et al, 1996
Intracranial Metastases of Hepatocellular Carcinoma: CT and MRI
Neuroradiology 38:531-535, Murakami, K.,et al, 1996
Isolated Body Lateropulsion Caused by a Lesion of the Cerebellar Peduncles
JNNP 60:356-357, Bertholon,P.,et al, 1996
Gait Disorders in Older Adults
J Am Geriatr Soc 44:434-452, Alexander,N.B., 1996
Patients with Multiple Sclerosis Presenting to Psychiatric Hospitals
J Clin Psychiatry 56:297-306, Pine,D.S.,et al, 1995
Cerebrospinal Fluid
JNNP 59:349-357, Thompson,E.J., 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995
Tumoral Multiple Sclerosis of the Cerebellum in a Child
AJNR 16:1164-1166, Rusin,J.A.,et al, 1995
Surgical Treatment of Temporal Lobe Epilepsy:Clinical, Radiological and Histopathological Findings in 178 Patients
JNNP 58:666-673, Zentner,J.,et al, 1995
Complex Partial Status Epilepticus Accompanied by Serious Morbidity and Mortality
Neurol 45:1499-1504, Krumholz,A.,et al, 1995
Bilaterally Symmetric Hippocampi and Surgical Outcome, Jack
Neurol 45:1353-1358, Jr,C.R.,et al, 1995
Hippocampal Volumetrics Differentiate Pts with Temporal Lobe Epilepsy & Extratemporal Lobe Epil
Arch Neurol 52:819-824, Gilmore,R.L.,et al, 1995
Preoperative MRI Predicts Outcome of Temporal Lobectomy:An Actuarial Analysis
Neurol 45:1358-1363, 12481995., Berkovic,S.F.,et al, 1995
Identification of Comatose Patients at High Risk for Death or Severe Disability
JAMA 273:1842-1848, Hamel,M.B.,et al, 1995
Neurofibromatosis 1 and Multiple Sclerosis
JNNP 58:582-585, Ferner,R.E.,et al, 1995
Reflex Sympathetic Dystrophy
BMJ 310:1645-1648, Paice,E., 1995
Mild Traumatic Brain Injury:Pathophysiology, Natural History, and Clinical Management
Neurol 45:1253-1260, 12511995., Alexander,M.P., 1995
Adverse Outcomes of Bacterial meningitis in School-Age Survivors
Pediatrics 95:646-655, Grimwood,K.,et al, 1995
The Eosinophilia-Myalgia Syndrome:Status of 205 Patients and Results of Treatment 2 Years After Onset
Ann Int Med 122:851-855, Hertzman,P.A.,et al, 1995
Multiphasic Disseminated Encephalomyelitis Presenting as Alternating Hemiplegia
JNNP 58:467-470, Khan,S.,et al, 1995
Multiple Sclerosis in the Spinal Cord, MR Appearance and Correlation with Clinical Parameters
Radiology 195:725-732, Tartaglino,L.M.,et al, 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Trigeminal Neuralgia in Multiple Sclerosis
Neurol 45:1294-1296, Hooge,J.P.&Redekop,W.K., 1995
Association Between Trigeminal Neuralgia and Multiple Sclerosis:Role of Magnetic Resonance Imaging
JNNP 59:253-259, Meaney,J.F.M.,et al, 1995
Clinical, Neurodiagnostic, and MR Findings in Children with Spinal & Brain Stem Multiple Sclerosis
AJNR 16:87-95, Glasier,C.M.,et al, 1995
Prediction of Long-Term Outcome in the Early Hours Following Acute Ischemic Stroke
Arch Neurol 52:250-255, Fiorelli,M.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995
Frequency of Anti-Nuclear Antibodies in Multiple Sclerosis
Neurol 45:384-385, Barned,S.,et al, 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995